help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on November 10, 2006, doi:10.1165/rcmb.2005-0425OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2005-0425OCv1
36/4/497    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, L.
Right arrow Articles by Ware, L. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, L.
Right arrow Articles by Ware, L. B.
American Journal of Respiratory Cell and Molecular Biology. Vol. 36, pp. 497-503, 2007
© 2007 American Thoracic Society
DOI: 10.1165/rcmb.2005-0425OC

Novel Role of the Human Alveolar Epithelium in Regulating Intra-Alveolar Coagulation

Ling Wang, Julie A. Bastarache, Nancy Wickersham, Xiaohui Fang, Michael A. Matthay and Lorraine B. Ware

Division of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee; Cardiovascular Research Institute; and Departments of Medicine and Anesthesia, University of California, San Francisco, California

Correspondence and requests for reprints should be addressed to Lorraine B. Ware, M.D., T1218 MCN, 1161 21st Avenue S, Nashville, TN 37232-2650. E-mail: lorraine.ware{at}vanderbilt.edu

Intra-alveolar fibrin deposition is a common response to localized and diffuse lung infection and acute lung injury (ALI). We hypothesized that the alveolar epithelium modulates intra-alveolar fibrin deposition through activation of protein C. Our obejctives were to determine whether components of the protein C activation pathway are present in the alveolar compartment in ALI and whether alveolar epithelium is a potential source. In patients with ALI, pulmonary edema fluid levels of endothelial protein C receptor (EPCR) were higher than plasma, suggesting a source in the lung. To determine whether alveolar epithelial cells are a potential source, protein C activation by A549, small airway epithelial, and primary human alveolar epithelial type II cells was measured. All three cell types express thrombomodulin (TM) and EPCR, and activate protein C on the cell surface. Activation of protein C was inhibited by cytomix (TNF-{alpha}, IL-1beta, and IFN-{gamma}). Release of EPCR and TM into the conditioned medium was inhibited by the metalloproteinase inhibitors tumor necrosis factor protease inhibitor (TAPI) and GM6001, indicating that the shedding of EPCR and TM from the alveolar epithelium is mediated by a metalloproteinase. These findings provide new evidence that the alveolar epithelium can modulate the protein C pathway and thus could be an important determinant of alveolar fibrin deposition. Local fibrin deposition may be a fundamental mechanism for the lung to localize and confine injury, thus limiting the risk of dissemination of injury or infection to the systemic circulation.

Key Words: alveolar epithelium • endothelium • protein C • coagulation • acute lung injury


CLINICAL RELEVANCE

The finding that thrombomodulin and endothelial protein C receptor can be released from lung epithelium by cytokine-induced metalloproteolytic cleavage adds to our understanding of fibrin deposition in the airspaces and may lead to new treatments for acute lung injury.

 



This article has been cited by other articles:


Home page
BloodHome page
C.-S. Shi, G.-Y. Shi, S.-M. Hsiao, Y.-C. Kao, K.-L. Kuo, C.-Y. Ma, C.-H. Kuo, B.-I. Chang, C.-F. Chang, C.-H. Lin, et al.
Lectin-like domain of thrombomodulin binds to its specific ligand Lewis Y antigen and neutralizes lipopolysaccharide-induced inflammatory response
Blood, November 1, 2008; 112(9): 3661 - 3670.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. A. Bastarache, L. Wang, Z. Wang, K. H. Albertine, M. A. Matthay, and L. B. Ware
Intra-alveolar tissue factor pathway inhibitor is not sufficient to block tissue factor procoagulant activity
Am J Physiol Lung Cell Mol Physiol, May 1, 2008; 294(5): L874 - L881.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
R. A. Oeckler and R. D. Hubmayr
Ventilator-associated lung injury: a search for better therapeutic targets
Eur. Respir. J., December 1, 2007; 30(6): 1216 - 1226.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2007 American Thoracic Society.
  ATS Best of the Web